Mitoguazone
![]() | |
![]() | |
| Clinical data | |
|---|---|
| ATC code | L01XX16 (WHO) |
| Identifiers | |
| |
| Synonyms | 2-[[(1E)-1-(Diaminomethylidenehydrazinylidene)propan-2-ylidene]amino]guanidine |
| CAS Number |
459-86-9 |
| PubChem (CID) | 5351154 |
| ChemSpider |
4508218 |
| UNII |
OD5Q0L447W |
| KEGG |
D07258 |
| ChEBI |
CHEBI:43996 |
| ECHA InfoCard | 100.121.515 |
| Chemical and physical data | |
| Formula | C5H12N8 |
| Molar mass | 184.20 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Mitoguazone (also known as methylglyoxal bis(guanylhydrazone) or MGBG) is a drug used in chemotherapy.
This article is issued from Wikipedia - version of the 12/2/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

